MindWalk Holdings Corp. (HYFT)
1.34
+0.01
(+0.75%)
USD |
NASDAQ |
Oct 02, 16:00
1.33
-0.01
(-0.75%)
After-Hours: 20:00
MindWalk Holdings EPS Diluted (Quarterly) : -0.0931 for July 31, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2026 | -0.0931 |
| April 30, 2026 | -0.0604 |
| January 31, 2026 | -0.0609 |
| October 31, 2025 | -0.0499 |
| July 31, 2025 | -0.0467 |
| April 30, 2025 | -0.0332 |
| January 31, 2025 | -0.4613 |
| October 31, 2024 | -0.0664 |
| July 31, 2024 | -0.1076 |
| April 30, 2024 | -0.4817 |
| January 31, 2024 | -0.0768 |
| October 31, 2023 | -0.0709 |
| July 31, 2023 | -0.1022 |
| April 30, 2023 | -0.1511 |
| January 31, 2023 | -0.1397 |
| October 31, 2022 | -0.2221 |
| July 31, 2022 | -0.2947 |
| April 30, 2022 | -0.1736 |
| January 31, 2022 | -0.1555 |
| October 31, 2021 | -0.206 |
| July 31, 2021 | -0.1367 |
| April 30, 2021 | -0.2371 |
| January 31, 2021 | -0.0595 |
| October 31, 2020 | -0.0224 |
| July 31, 2020 | -0.0278 |
| Date | Value |
|---|---|
| April 30, 2020 | -0.0491 |
| January 31, 2020 | -0.0349 |
| October 31, 2019 | -0.0757 |
| July 31, 2019 | -0.1114 |
| April 30, 2019 | -0.2123 |
| January 31, 2019 | -0.0664 |
| October 31, 2018 | -0.0944 |
| July 31, 2018 | -0.0767 |
| April 30, 2018 | -0.1568 |
| January 31, 2018 | -0.1013 |
| October 31, 2017 | -0.08 |
| July 31, 2017 | -0.0757 |
| April 30, 2017 | -0.1127 |
| January 31, 2017 | -0.9755 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | -0.0551 |
| June 30, 2014 | 0.0023 |
| March 31, 2014 | -0.031 |
| December 31, 2013 | -0.0858 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Repligen Corp. | 0.0884 |
| Bio-Techne Corp. | 0.348 |
| BioLife Solutions, Inc. | 0.915 |
| Maravai Lifesciences Holdings, Inc. | -0.0839 |
| MaxCyte, Inc. | -0.0831 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.358M |
| Revenue (Quarterly) | 2.746M |
| Total Expenses (Quarterly) | 7.103M |
| Enterprise Value | 60.02M |
| Gross Profit Margin (Quarterly) | 58.58% |
| Profit Margin (Quarterly) | -158.7% |
| Earnings Yield | -19.72% |
| Normalized Earnings Yield | -19.72 |